|
|
Suppliers for
Imatinib
|
Properties | CAS |
152459-95-5 | Formula |
C29H31N7O |
|
|
14 Registered suppliers
Appearance | Yellowish to white crystalline powder
| Solubility | Soluble in water and sparingly soluble in methanol
| Identification | NMR, HPLC,IR
| Loss on Drying | ≤ 0.5%
| Residue on Ignition | ≤ 0.2%
| Heavy Metals | ≤ 20ppm
| Total impurity | ≤ 1.5%
| Single impurity | ≤ 0.5%
| Assay | ≥ 98.5% |
Appearance | Yellowish to white crystalline powder
| Solubility | Soluble in water and sparingly soluble in methanol
| Identification | NMR, HPLC,IR
| Loss on Drying | ≤ 0.5%
| Residue on Ignition | ≤ 0.2%
| Heavy Metals | ≤ 20ppm
| Total impurity | ≤ 1.5%
| Single impurity | ≤ 0.5%
| Assay | ≥ 98.5% |
Appearance | Yellowish to white crystalline powder
| Solubility | Soluble in water and sparingly soluble in methanol
| Identification | NMR, HPLC,IR
| Loss on Drying | ≤ 0.5%
| Residue on Ignition | ≤ 0.2%
| Heavy Metals | ≤ 20ppm
| Total impurity | ≤ 1.5%
| Single impurity | ≤ 0.5%
| Assay | ≥ 98.5% |
Molecular Formula: C29H31N7O Molecular Weight: 493.6 HS Code: 29339900
More details are to be found here
Molecular Formula: C29H31N7O Molecular Weight: 493.6 HS Code: 29339900
More details are to be found here
Molecular Formula: C29H31N7O Molecular Weight: 493.6 HS Code: 29339900
More details are to be found here
Description : Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with an IC50 for these effects of approximately 0.1 μM, which is similar to the concentration required for inhibition of PDGFR. Imatinib is an oral chemotherapy agent used to treat cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome. - Molecular Weight :493.60
- Boiling Point :451°C
- Melting Point :207-209°C
- Purity :> 98%
Molecular Formula : C29H31N7O Canonical SMILES : CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 InChI : InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) InChIKey : KTUFNOKKBVMGRW-UHFFFAOYSA-N Solubility : Soluble in DMSO (Slightly, Heated), Methanol (Slightly, Heated) Appearance : White to Off-white Solid Storage : Store at -20°C Synonyms : CGP057148B; STI571; Gleevec; Glivec; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide
More details are to be found here
Description : Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with an IC50 for these effects of approximately 0.1 μM, which is similar to the concentration required for inhibition of PDGFR. Imatinib is an oral chemotherapy agent used to treat cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome. - Molecular Weight :493.60
- Boiling Point :451°C
- Melting Point :207-209°C
- Purity :> 98%
Molecular Formula : C29H31N7O Canonical SMILES : CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 InChI : InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) InChIKey : KTUFNOKKBVMGRW-UHFFFAOYSA-N Solubility : Soluble in DMSO (Slightly, Heated), Methanol (Slightly, Heated) Appearance : White to Off-white Solid Storage : Store at -20°C Synonyms : CGP057148B; STI571; Gleevec; Glivec; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide
More details are to be found here
Purity : 98% Smile code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4 MDL Number : MFCD05662257 MolFormula : C29H31N7O MolWeight : 493.6028 Available in stock : 881.011
More details are to be found here
Purity : 98% Smile code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4 MDL Number : MFCD05662257 MolFormula : C29H31N7O MolWeight : 493.6028 Available in stock : 881.011
More details are to be found here
Purity : 98% Smile code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4 MDL Number : MFCD05662257 MolFormula : C29H31N7O MolWeight : 493.6028 Available in stock : 881.011
More details are to be found here
Purity : 98% Smile code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4 MDL Number : MFCD05662257 MolFormula : C29H31N7O MolWeight : 493.6028 Available in stock : 881.011
More details are to be found here
Purity : 98% Smile code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4 MDL Number : MFCD05662257 MolFormula : C29H31N7O MolWeight : 493.6028 Available in stock : 881.011
More details are to be found here
Detailed information on the suppliers of
Imatinib
|
Properties:
... more properties and specification on Imatinib
|
|
Privileged suppliers
Last update 2024-04-25
|